NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer

被引：5

作者：

Rinaldi, Fiona ^{[1
]}

George, Elisabeth ^{[1
]}

Clark, Peter ^{[1
]}

机构：

[1] Natl Inst Hlth & Clin Excellence, Manchester, Lancs, England

来源：

LANCET ONCOLOGY | 2011年 / 12卷 / 08期

关键词：

D O I：

10.1016/S1470-2045(11)70177-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：728 / 730

页数：3

共 11 条

[1]

[Anonymous], ERL MON MAINT TREATM

[2]

[Anonymous], NICE TECHN APPR GUID

[3]

[Anonymous], TECHN APPR GUID TA22

[4]

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study [J].

Cappuzzo, Federico ;

Ciuleanu, Tudor ;

Stelmakh, Lilia ;

Cicenas, Saulius ;

Szczesna, Aleksandra ;

Juhasz, Erzsebet ;

Esteban, Emilio ;

Molinier, Olivier ;

Brugger, Wolfram ;

Melezinek, Ivan ;

Klingelschmitt, Gaelle ;

Klughammer, Barbara ;

Giaccone, Giuseppe .

LANCET ONCOLOGY, 2010, 11 (06) :521-529

[5]

National Institute for Health and Care Excellence (NICE), 2009, Appraising life-extending, end of life treatments

[6]

*NICE, 2010, 2 APPR CONS DOC LUNG

[7]

*NICE, 2011, NOT APP LUNG CANC NO

[8]

*NICE, 2011, FIN APPR DET LUNG CA

[9]

*NICE, 2009, FIN SCOP LUNG CANC N

[10]

*NICE, 2010, MAN SUBM ERL 1 LIN M

← 1 2 →